Modification of TRPV4 activity by acetaminophen.

Area of Science:

• Pharmacology
• Molecular Biology
• Neuroscience

Background:

• N-Acetyl-p-aminophenol (APAP), a common analgesic and antipyretic, has unclear molecular mechanisms, with known effects mediated by metabolites acting on TRP channels.
• Previous observations indicated APAP promotes cell migration via TRPV4, prompting investigation into its direct effects on TRPV4 calcium channel activity.

Purpose of the Study:

• To investigate the effect of APAP on the calcium (Ca2+) channel activity of TRPV4.
• To determine if APAP directly interacts with TRPV4 or if its effects are mediated by metabolites.

Main Methods:

• Utilized rat PC12 and human HeLa cell lines engineered to express TRPV4 (HeLa-mTRPV4).
• Measured intracellular calcium ([Ca2+]i) levels following stimulation with TRPV4 agonist GSK1016790A (GSK).
• Assessed the impact of APAP and its potential metabolites on GSK-induced Ca2+ influx.

Main Results:

• APAP dose-dependently inhibited GSK-induced Ca2+ entry through TRPV4 in both PC12 and HeLa-mTRPV4 cells.
• APAP alone did not alter basal [Ca2+]i levels, indicating specific modulation of TRPV4 activity.
• The rapid onset of APAP's effect suggests it acts directly on TRPV4, independent of its metabolites.

Conclusions:

• APAP directly suppresses TRPV4 channel activity, representing a novel molecular mechanism for its therapeutic effects.
• This direct action on TRPV4 contrasts with APAP's known activation of TRPV1 and TRPA1 channels via its metabolites.
• The findings suggest APAP's antipyretic and analgesic properties may be partly mediated by its direct interaction with TRPV4.